Felicitex Therapeutics is a drug discovery company at the forefront of one of the most promising areas in oncology - quiescent (sleeping) cancer cells. We are developing treatments and diagnostic assays to improve the effectiveness and long-term outcomes of treatments for the deadliest and most resistant to therapy cancers: pancreatic, colorectal, non-small cell lung, and ovarian.

Oncology Cancer Drug Development Quiescence Dormancy

Pancreatic Ovarian Colon Small Molecule Personalized Medicine

Contact:	919-213-0025
Address:	One Kendall Sq. Cambridge, Massachusetts   02139 , USA
Fax:	919-213-0025
Year Established:	2012